• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

软组织肉瘤初诊患者肺转移风险和总生存评分:一种基于列线图的新风险评估系统。

Score for the Risk and Overall Survival of Lung Metastasis in Patients First Diagnosed With Soft Tissue Sarcoma: A Novel Nomogram-Based Risk Assessment System.

机构信息

The People's Hospital of Lishui, Lishui, Zhejiang, 323000, China.

Affiliated Hospital of Chengde Medical University, Chengde, Hebei 067000, China.

出版信息

Technol Cancer Res Treat. 2022 Jan-Dec;21:15330338211066240. doi: 10.1177/15330338211066240.

DOI:10.1177/15330338211066240
PMID:35006028
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8753250/
Abstract

Metastatic soft tissue sarcoma (STS) patients have a poor prognosis with a 3-year survival rate of 25%. About 30% of them present lung metastases (LM). This study aimed to construct 2 nomograms to predict the risk of LM and overall survival of STS patients with LM. The data of patients were derived from the Surveillance, Epidemiology, and End Results database during the period of 2010 to 2015. Logistic and Cox analysis was performed to determine the independent risk factors and prognostic factors of STS patients with LM, respectively. Afterward, 2 nomograms were, respectively, established based on these factors. The performance of the developed nomogram was evaluated with receiver operating characteristic curves, area under the curve (AUC) calibration curves, and decision curve analysis (DCA). A total of 7643 patients with STS were included in this study. The independent predictors of LM in first-diagnosed STS patients were N stage, grade, histologic type, and tumor size. The independent prognostic factors for STS patients with LM were age, N stage, surgery, and chemotherapy. The AUCs of the diagnostic nomogram were 0.806 in the training set and 0.799 in the testing set. For the prognostic nomogram, the time-dependent AUC values of the training and testing set suggested a favorable performance and discrimination of the nomogram. The 1-, 2-, and 3-year AUC values were 0.698, 0.718, and 0.715 in the training set, and 0.669, 0.612, and 0717 in the testing set, respectively. Furthermore, for the 2 nomograms, calibration curves indicated satisfactory agreement between prediction and actual survival, and DCA indicated its clinical usefulness. In this study, grade, histology, N stage, and tumor size were identified as independent risk factors of LM in STS patients, age, chemotherapy surgery, and N stage were identified as independent prognostic factors of STS patients with LM, these developed nomograms may be an effective tool for accurately predicting the risk and prognosis of newly diagnosed patients with LM.

摘要

转移性软组织肉瘤(STS)患者预后较差,3 年生存率为 25%。约 30%的患者出现肺转移(LM)。本研究旨在构建 2 个列线图,以预测 STS 患者 LM 风险和总生存情况。数据来自 2010 年至 2015 年期间监测、流行病学和最终结果数据库。使用逻辑和 Cox 分析分别确定 STS 患者 LM 的独立危险因素和预后因素。此后,根据这些因素分别建立了 2 个列线图。通过受试者工作特征曲线、曲线下面积(AUC)校准曲线和决策曲线分析(DCA)评估开发的列线图的性能。共有 7643 名 STS 患者纳入本研究。首次诊断为 STS 患者 LM 的独立预测因素为 N 分期、分级、组织学类型和肿瘤大小。STS 患者 LM 的独立预后因素为年龄、N 分期、手术和化疗。诊断列线图在训练集中的 AUC 为 0.806,在测试集中为 0.799。对于预后列线图,训练集和测试集的时间依赖性 AUC 值表明该列线图具有良好的性能和区分度。训练集中 1 年、2 年和 3 年的 AUC 值分别为 0.698、0.718 和 0.715,测试集中分别为 0.669、0.612 和 0717。此外,对于这 2 个列线图,校准曲线表明预测与实际生存之间存在良好的一致性,DCA 表明其具有临床实用性。在本研究中,分级、组织学、N 分期和肿瘤大小被确定为 STS 患者 LM 的独立危险因素,年龄、化疗、手术和 N 分期被确定为 STS 患者 LM 的独立预后因素,这些开发的列线图可能是准确预测新诊断 LM 患者风险和预后的有效工具。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4443/8753250/b9eaddf99bc1/10.1177_15330338211066240-fig8.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4443/8753250/e8df958beecd/10.1177_15330338211066240-fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4443/8753250/d35b0026612f/10.1177_15330338211066240-fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4443/8753250/c330d1f37e90/10.1177_15330338211066240-fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4443/8753250/15d6e0c5b4a7/10.1177_15330338211066240-fig4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4443/8753250/88d1e09644c7/10.1177_15330338211066240-fig5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4443/8753250/37f557c97186/10.1177_15330338211066240-fig7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4443/8753250/b9eaddf99bc1/10.1177_15330338211066240-fig8.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4443/8753250/e8df958beecd/10.1177_15330338211066240-fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4443/8753250/d35b0026612f/10.1177_15330338211066240-fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4443/8753250/c330d1f37e90/10.1177_15330338211066240-fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4443/8753250/15d6e0c5b4a7/10.1177_15330338211066240-fig4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4443/8753250/88d1e09644c7/10.1177_15330338211066240-fig5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4443/8753250/37f557c97186/10.1177_15330338211066240-fig7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4443/8753250/b9eaddf99bc1/10.1177_15330338211066240-fig8.jpg

相似文献

1
Score for the Risk and Overall Survival of Lung Metastasis in Patients First Diagnosed With Soft Tissue Sarcoma: A Novel Nomogram-Based Risk Assessment System.软组织肉瘤初诊患者肺转移风险和总生存评分:一种基于列线图的新风险评估系统。
Technol Cancer Res Treat. 2022 Jan-Dec;21:15330338211066240. doi: 10.1177/15330338211066240.
2
Development and Validation of Novel Nomograms for Predicting Specific Distant Metastatic Sites and Overall Survival of Patients With Soft Tissue Sarcoma.软组织肉瘤患者特定远处转移部位和总生存的新型列线图的建立和验证。
Technol Cancer Res Treat. 2021 Jan-Dec;20:1533033821997828. doi: 10.1177/1533033821997828.
3
Early distinction of lymph node metastasis in patients with soft tissue sarcoma and individualized survival prediction using the online available nomograms: A population-based analysis.软组织肉瘤患者淋巴结转移的早期鉴别及使用在线可用列线图进行个体化生存预测:一项基于人群的分析
Front Oncol. 2022 Dec 7;12:959804. doi: 10.3389/fonc.2022.959804. eCollection 2022.
4
Diagnostic and prognostic nomograms for laryngeal carcinoma patients with lung metastasis: a SEER-based study.喉癌肺转移患者的诊断和预后列线图:一项基于监测、流行病学和最终结果(SEER)数据库的研究
Eur Arch Otorhinolaryngol. 2024 Jun;281(6):3071-3082. doi: 10.1007/s00405-024-08608-x. Epub 2024 Apr 7.
5
Development and Validation of Nomograms to Assess Risk Factors and Overall Survival Prediction for Lung Metastasis in Young Patients with Osteosarcoma: A SEER-Based Study.基于 SEER 数据库的研究:建立并验证列线图模型评估骨肉瘤青年患者肺转移的危险因素及总体生存预测。
Int J Clin Pract. 2022 Oct 25;2022:8568724. doi: 10.1155/2022/8568724. eCollection 2022.
6
Diagnostic and prognostic nomograms for bone metastasis in hepatocellular carcinoma.肝癌骨转移的诊断和预后列线图。
BMC Cancer. 2020 Jun 1;20(1):494. doi: 10.1186/s12885-020-06995-y.
7
An updated incidence trends of soft-tissue sarcoma and cancer-specific survival of patients with primary soft-tissue sarcoma of liver: a population-based study.基于人群的研究:肝原发性软组织肉瘤患者软组织肉瘤的发病率变化趋势和癌症特异性生存情况。
Expert Rev Gastroenterol Hepatol. 2021 Jun;15(6):689-698. doi: 10.1080/17474124.2021.1842193. Epub 2020 Nov 13.
8
Diagnostic and Prognostic Nomograms for Lung Metastasis in Triple-Negative Breast Cancer.三阴性乳腺癌肺转移的诊断和预后列线图
Comput Math Methods Med. 2022 Aug 11;2022:1750834. doi: 10.1155/2022/1750834. eCollection 2022.
9
A novel nomogram and prognostic factor for metastatic soft tissue sarcoma survival.一种用于转移性软组织肉瘤生存的新型列线图和预后因素。
Front Endocrinol (Lausanne). 2024 May 13;15:1371910. doi: 10.3389/fendo.2024.1371910. eCollection 2024.
10
Prognostic Nomogram for Overall Survival in Small Cell Lung Cancer Patients Treated with Chemotherapy: A SEER-Based Retrospective Cohort Study.化疗治疗小细胞肺癌患者总生存预后列线图:基于 SEER 的回顾性队列研究。
Adv Ther. 2022 Jan;39(1):346-359. doi: 10.1007/s12325-021-01974-6. Epub 2021 Nov 3.

引用本文的文献

1
Predefined and data-driven CT radiomics predict recurrence-free and overall survival in patients with pulmonary metastases treated with stereotactic body radiotherapy.预定义和数据驱动的CT影像组学可预测接受立体定向体部放疗的肺转移患者的无复发生存期和总生存期。
PLoS One. 2024 Dec 31;19(12):e0311910. doi: 10.1371/journal.pone.0311910. eCollection 2024.
2
Feasibility and therapeutic potential of [Lu]Lu-FAPI-2286 in patients with advanced metastatic sarcoma.[镥-177]Lu-FAPI-2286 治疗晚期转移性肉瘤患者的可行性和治疗潜力。
Eur J Nucl Med Mol Imaging. 2024 Dec;52(1):237-246. doi: 10.1007/s00259-024-06795-7. Epub 2024 Jul 27.
3

本文引用的文献

1
Surgical resection of primary tumor in the extremities improves survival for metastatic soft-tissue sarcoma patients: a population-based study of the SEER database.四肢原发性肿瘤的外科切除可改善转移性软组织肉瘤患者的生存:SEER 数据库的一项基于人群的研究。
Clin Transl Oncol. 2021 Dec;23(12):2474-2481. doi: 10.1007/s12094-021-02646-1. Epub 2021 Jun 1.
2
Randomized Comparison of Pazopanib and Doxorubicin as First-Line Treatment in Patients With Metastatic Soft Tissue Sarcoma Age 60 Years or Older: Results of a German Intergroup Study.帕唑帕尼与多柔比星一线治疗 60 岁及以上转移性软组织肉瘤患者的随机比较:德国协作组研究结果。
J Clin Oncol. 2020 Oct 20;38(30):3555-3564. doi: 10.1200/JCO.20.00714. Epub 2020 Aug 24.
3
A novel nomogram and prognostic factor for metastatic soft tissue sarcoma survival.
一种用于转移性软组织肉瘤生存的新型列线图和预后因素。
Front Endocrinol (Lausanne). 2024 May 13;15:1371910. doi: 10.3389/fendo.2024.1371910. eCollection 2024.
4
Review on Lymph Node Metastases, Sentinel Lymph Node Biopsy, and Lymphadenectomy in Sarcoma.肉瘤中的淋巴结转移、前哨淋巴结活检和淋巴结清扫术的研究进展。
Curr Oncol. 2024 Jan 5;31(1):307-323. doi: 10.3390/curroncol31010020.
5
Potential Medical Use of Fullerenols After Two Decades of Oncology Research.富勒醇在肿瘤学研究二十年之后的潜在医学用途。
Technol Cancer Res Treat. 2023 Jan-Dec;22:15330338231201515. doi: 10.1177/15330338231201515.
6
Early distinction of lymph node metastasis in patients with soft tissue sarcoma and individualized survival prediction using the online available nomograms: A population-based analysis.软组织肉瘤患者淋巴结转移的早期鉴别及使用在线可用列线图进行个体化生存预测:一项基于人群的分析
Front Oncol. 2022 Dec 7;12:959804. doi: 10.3389/fonc.2022.959804. eCollection 2022.
7
Risk Factors of Early Distant Metastasis After Primary Tumor Treatment in Soft Tissue Sarcoma.软组织肉瘤原发灶治疗后早期远处转移的危险因素。
In Vivo. 2022 Sep-Oct;36(5):2260-2264. doi: 10.21873/invivo.12954.
Prognostic influence of the treatment approach for pulmonary metastasis in patients with soft tissue sarcoma.
软组织肉瘤患者肺转移治疗方式的预后影响。
Clin Exp Metastasis. 2020 Aug;37(4):509-517. doi: 10.1007/s10585-020-10038-y. Epub 2020 May 20.
4
Effect of Doxorubicin Plus Olaratumab vs Doxorubicin Plus Placebo on Survival in Patients With Advanced Soft Tissue Sarcomas: The ANNOUNCE Randomized Clinical Trial.多柔比星联合奥拉单抗对比多柔比星联合安慰剂治疗晚期软组织肉瘤患者的生存影响:ANNOUNCE 随机临床试验。
JAMA. 2020 Apr 7;323(13):1266-1276. doi: 10.1001/jama.2020.1707.
5
Stereotactic Body Radiotherapy Versus Metastasectomy in Patients With Pulmonary Metastases From Soft Tissue Sarcoma.立体定向体部放疗与转移瘤切除术治疗软组织肉瘤肺转移患者的比较。
Clin Oncol (R Coll Radiol). 2020 May;32(5):303-315. doi: 10.1016/j.clon.2020.01.005. Epub 2020 Feb 2.
6
Risk factors for lung metastasis at presentation with malignant primary osseous neoplasms: a population-based study.恶性原发性骨肿瘤初诊时肺转移的危险因素:一项基于人群的研究。
J Orthop Surg Res. 2020 Jan 29;15(1):32. doi: 10.1186/s13018-020-1571-5.
7
Early Lymph Node Metastasis May Predict Poor Prognosis in Soft Tissue Sarcoma.早期淋巴结转移可能预示软组织肉瘤预后不良。
Int J Surg Oncol. 2019 Dec 12;2019:6708474. doi: 10.1155/2019/6708474. eCollection 2019.
8
Development and external validation of a dynamic prognostic nomogram for primary extremity soft tissue sarcoma survivors.原发性肢体软组织肉瘤幸存者动态预后列线图的开发与外部验证
EClinicalMedicine. 2019 Nov 22;17:100215. doi: 10.1016/j.eclinm.2019.11.008. eCollection 2019 Dec.
9
Lung Surveillance Strategy for High-Grade Soft Tissue Sarcomas: Chest X-Ray or CT Scan?肺部监测策略在高级软组织肉瘤中的应用:胸部 X 光片还是 CT 扫描?
J Am Coll Surg. 2019 Nov;229(5):449-457. doi: 10.1016/j.jamcollsurg.2019.07.010. Epub 2019 Aug 1.
10
Survival analysis of patients with metastatic osteosarcoma: a Surveillance, Epidemiology, and End Results population-based study.转移性骨肉瘤患者的生存分析:一项监测、流行病学和最终结果的基于人群的研究。
Int Orthop. 2019 Aug;43(8):1983-1991. doi: 10.1007/s00264-019-04348-4. Epub 2019 May 24.